← FDA DRUG APPROVALS

FDA ANDA · ANDA083288

QUINIDINE SULFATE

Sponsor: WATSON LABS

APPLICATION
ANDA083288
TYPE
ANDA
ORIGINAL APPROVAL
1976-11-24
LATEST ACTION
2001-04-25
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

QUINIDINE SULFATEDiscontinued
QUINIDINE SULFATE 200MG · TABLET · ORAL

Approval history

2001-04-25Manufacturing (CMC) · Supplement 71AP
1998-03-09Manufacturing (CMC) · Supplement 69AP
1997-11-20Manufacturing (CMC) · Supplement 68AP
1996-06-10Labeling · Supplement 67AP
1994-09-15Manufacturing (CMC) · Supplement 66AP
1991-08-07Manufacturing (CMC) · Supplement 64AP
1991-01-28Manufacturing (CMC) · Supplement 65AP
1990-06-29Manufacturing (CMC) · Supplement 63AP
1989-07-13Labeling · Supplement 62AP
1989-04-25Labeling · Supplement 61AP
1988-12-07Labeling · Supplement 60AP
1988-05-06Manufacturing (CMC) · Supplement 57AP
1988-05-06Manufacturing (CMC) · Supplement 58AP
1988-05-06Manufacturing (CMC) · Supplement 59AP
1985-08-19Manufacturing (CMC) · Supplement 49AP
1985-08-19Manufacturing (CMC) · Supplement 53AP
1985-08-19Manufacturing (CMC) · Supplement 50AP
1985-06-07Manufacturing (CMC) · Supplement 55AP
1985-06-07Manufacturing (CMC) · Supplement 54AP
1985-01-24Manufacturing (CMC) · Supplement 48AP
1983-05-23Manufacturing (CMC) · Supplement 45AP
1983-05-23Manufacturing (CMC) · Supplement 44AP
1976-11-24OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →